Phase 1 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged between 18 and 75 years, with a good general activity level and an expected survival of more than 3 months.
- People who have been diagnosed with locally advanced or metastatic non-small cell lung cancer (a type of lung cancer that has spread or cannot be removed by surgery), confirmed by a tissue or cell sample.
- People whose major organs (such as heart, liver, and kidneys) are working well.
- Women who are not pregnant (confirmed by a blood test within 7 days before starting the trial) and not breastfeeding; both women and men who could potentially have children must agree to use contraception throughout the study and for 6 months after it ends.
- People who are willing to take part voluntarily, have signed a consent form, and are expected to follow the study requirements.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have had another type of cancer within the past 5 years, at the same time as their current diagnosis.
- People still experiencing side effects above a mild level from any previous cancer treatment.
- People who have had major surgery, a biopsy, or a significant injury within 28 days before starting the trial.
- People with wounds or broken bones that have not healed over a long period.
- People who have had a stroke, mini-stroke, blood clot in a deep vein, or a blood clot in the lungs within the past 6 months.
- People with a history of misusing mind-altering substances and who are unable to stop, or people with a diagnosed mental health disorder.
- People with any serious or uncontrolled illness or medical condition.
- People who have received a live vaccine within 2 weeks before starting the trial, or who plan to receive a live vaccine during the study.
- People with a history of unexplained severe allergies, or who have had a reaction to monoclonal antibody medicines, human immunoglobulin products, or to the study drug (TQB2928) or its ingredients.
- People whom the study doctor considers unsuitable for the trial due to other health conditions or concerns that could affect their safety or their ability to complete the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 020-87343458
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Phase II recommended combination doses (RP2CD); Objective Response Rate (ORR); Duration of Response (DOR); Progression-free survival (PFS); Time to Progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.